1998
DOI: 10.1016/s0167-5273(98)00116-8
|View full text |Cite
|
Sign up to set email alerts
|

Humoral response in patients with chronic heart failure

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
3
0
2

Year Published

2004
2004
2020
2020

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 9 publications
(6 citation statements)
references
References 18 publications
1
3
0
2
Order By: Relevance
“…In addition, activation of the neuroendocrine system in patients with chronic heart failure leads to increased levels of norepinephrine, angiotensin II, arginine vasopressin, endothelin, thromboxane A2 and prostaglandin F in the blood vessels, vasoconstriction leads to renal ischemia, resulting in decreased erythropoietin synthesis, therefore reduced erythropoiesis eventually cause anemia. 21 And renal insufficiency eventually leads to Anemia caused by a decrease in EPO, and also we found that in RDW in patients with CHF is more closely associated with Glomerular filtration rate. 22…”
Section: Anemia-related Mechanismssupporting
confidence: 62%
“…In addition, activation of the neuroendocrine system in patients with chronic heart failure leads to increased levels of norepinephrine, angiotensin II, arginine vasopressin, endothelin, thromboxane A2 and prostaglandin F in the blood vessels, vasoconstriction leads to renal ischemia, resulting in decreased erythropoietin synthesis, therefore reduced erythropoiesis eventually cause anemia. 21 And renal insufficiency eventually leads to Anemia caused by a decrease in EPO, and also we found that in RDW in patients with CHF is more closely associated with Glomerular filtration rate. 22…”
Section: Anemia-related Mechanismssupporting
confidence: 62%
“…In CHF patients, big ET1 is used primarily as a prognostic marker [15,[22][23][24][25]. Natriuretic peptides have been widely used in the evaluation of diagnosis and prognosis in patients with CHF; hence, they are also of value in long term CHF management.…”
Section: Current Clinical Applications Of Big Et1 and Bnp In Patientsmentioning
confidence: 99%
“…Increased RDW may comprehensively reflect the following pathophysiological mechanisms in occurrence and development of sepsis: a) inflammation may cause an increase of neuro-hormone and endocrine hormone in the body including noradrenaline, angiotensin1 and other angiotensins level and renal ischemia. These neurotransmitters can stimulate red blood cell proliferation through promoting the generation of erythropoietin (EPO) to result in RDW increase [12]. b) Inflammatory factors may affect marrow hemopoietic function and iron metabolism in the body to cause RDW increase [13,14].…”
Section: Introductionmentioning
confidence: 99%